... Prevention
Infección aguda — University of California San Francisco
Barriers and Facilitators to HIV/AIDS Testing Among Latin Immigrant Men Who Have Sex With Men (MSM): A Systematic Review of the Literature — The Open AIDS Journal
Factors Associated With HIV Testing Among Spanish and English-Speaking Latino Adolescents Aged 13–18 — AIDS and Behavior ...
¿Cuánto tarda en detectarse el VIH tras el contagio?
... Prevention
Infección aguda — University of California San Francisco
Barriers and Facilitators to HIV/AIDS Testing Among Latin Immigrant Men Who Have Sex With Men (MSM): A Systematic Review of the Literature — The Open AIDS Journal
Factors Associated With HIV Testing Among Spanish and English-Speaking Latino Adolescents Aged 13–18 — AIDS and Behavior ...
... — Institutos Nacionales de Salud (NIH)
México refuerza el acceso universal al diagnóstico y tratamiento del VIH y SIDA — ConsultorSalud
HIV Testing and Outcomes Among Hispanics/Latinos; United States, Puerto Rico, and U.S. ...
¿El VIH puede detectarse en cualquier análisis de sangre?
... — Institutos Nacionales de Salud (NIH)
México refuerza el acceso universal al diagnóstico y tratamiento del VIH y SIDA — ConsultorSalud
HIV Testing and Outcomes Among Hispanics/Latinos; United States, Puerto Rico, and U.S. ...
...
Regulation of Nausea and Vomiting by Cannabinoids — British Journal of Pharmacology
Label: Dronabinol Capsule — DailyMed
Clinical Utility of Dronabinol in the Treatment of Weight Loss Associated With HIV and AIDS — HIV/AIDS: Research and Palliative Care
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers. ...
Marihuana médica y VIH: ¿puede ayudar?
...
Regulation of Nausea and Vomiting by Cannabinoids — British Journal of Pharmacology
Label: Dronabinol Capsule — DailyMed
Clinical Utility of Dronabinol in the Treatment of Weight Loss Associated With HIV and AIDS — HIV/AIDS: Research and Palliative Care
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers. ...
... the Risk of Getting HIV — U.S. ...
... Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-208 — Clinical Infectious Diseases ...
... — Science
Two-Thirds of People Living With HIV Would Like To Try Injectable Treatment, According to European Survey — Aidsmap
Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States — Advances in Therapy
...
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead Sciences
Let’s Stop HIV Together — Centers for Disease Control and Prevention
Undetectable Viral Load and HIV Transmission — ...
VIH: causa, prevención y factores de riesgo
... Food and Drug Administration
FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo — Drugs.com
Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection — Gilead Sciences
Let’s Stop HIV Together — Centers for Disease Control and Prevention
Undetectable Viral Load and HIV Transmission — ...
... Sleep — Mayo Clinic
Myths and Facts About Sleep — Sleep Foundation
Fatigue Is Associated With Worse Cognitive and Everyday Functioning in Older Persons With HIV — AIDS ...
... of AIDS Care
Privacy, Confidentiality and Disclosure — Lambda Legal
HIV and Privacy Laws: What You Need To Know — PrEP Daily
Sharing Your Status — Be in the Know
Disclosure of HIV-Positive Status: Towards the Development of Guidelines, Strategies and Interventions — Rapid Response Service
...
Consejos para hablar sobre su diagnóstico de VIH con otras personas
... of AIDS Care
Privacy, Confidentiality and Disclosure — Lambda Legal
HIV and Privacy Laws: What You Need To Know — PrEP Daily
Sharing Your Status — Be in the Know
Disclosure of HIV-Positive Status: Towards the Development of Guidelines, Strategies and Interventions — Rapid Response Service
...
únete
